Board of Directors

Allan W. Wolkoff, MD
Albert Einstein College of Medicine, Bronx, New York

Rick Smith
American Liver Foundation, New York, New York

Frank Uvena
Secretary, Chicago, Illinois

Eddie Cheung, MD, FACG
University of California, Davis, Martinez, California

Richard M. Colton
Sharebridge Private Equity Consolidated, New York, New York

Donna R. Cryer, JD
Cryerhealth, LLC, Washington, D.C.

Nicholas J. DeRoma
New Canaan, Connecticut

Frank Dzvonik
Abbott Laboratories, Alameda, California

Norman D. Grace, MD
Brigham and Women's Hospital, Boston, Massachusetts

Louise M. Jacobbi
Saturn Management Research, Metairie, Louisiana

Ira M. Jacobson, MD
Weill Cornell Medical College, New York, New York

George Jamieson, CPA
PricewaterhouseCoopers - Retired, New London, New Hampshire

Michael Kerr
Woodsburgh, New York

Paul Martin, MD
University of Miami, Miami, Florida

Chris McCarrick
Velocity Group, Inc., Alexandria, Virginia

Thomas F. Nealon III
LNR Partners, Inc., Miami Beach, Florida

Bruce F. Scharschmidt, MD
Hyperion Therapeutics, South San Francisco, California

Ronald J. Sokol, MD
University of Colorado Denver School of Medicine, Aurora, Colorado

Susan Sherman Stone
Hingham, Massachusetts

Frederick J. Suchy, MD
The Mount Sinai Hospital, New York, New York

Douglas G. Watson
Pittencrief Glen Associates, Far Hills, New Jersey

Edmund Blake
Pinnacle Associates, Ltd., New York, New York

Thomas E. Starzl, MD
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania